Back to Top Skip to main content Skip to sub-navigation

Medical lab workers ensure readiness and wellness behind the scenes

Image of woman in lab coat looking at samples in test tubes Senior Airman Brittany Campbell prepares urinalysis samples for testing. (U.S. Air Force photo by Tech. Sgt. James Hodgman)

Recommended Content:

Public Health | Coronavirus | Heroes Behind the Mask

Medical laboratory professionals usually work behind the scenes, performing vital duties to ensure the health and readiness of the force. But they come front and center this week, as National Medical Laboratory Professionals Week shines a spotlight on their work and this year’s Fellowship of the Lab theme.

Across the Military Health System, medical lab professionals are involved in every aspect of health care. As the MHS devotes resources to support the COVID-19 pandemic response, lab workers are analyzing tests that detect the contagious respiratory virus.

"We're fortunate to be a vital piece to the COVID-19 pandemic response by standing up in-house testing," said Air Force Lt. Michael Moeun, chief of microbiology at David Grant USAF Medical Center laboratory at Travis Air Force Base, California. The David Grant lab supports Air Mobility Command and the Pacific Theater.

"We could not be more proud to support Team Travis and our patients," Moeun said.

Since the first reports of the new virus Dec. 31, approximately 2.5 million cases of COVID-19 have occurred globally, according to the U.S. Centers for Disease Control and Prevention. The Department of Defense is working closely with the Department of Health and Human Services and U.S. State Department to provide support in dealing with the outbreak.

MHS laboratory capabilities are synchronized through the Center for Laboratory Medicine Services and the Executive Secretariat, DoD Laboratory Network. Currently, COVID-19 testing is being performed at 68 Army, Navy, and Air Force facilities across the DoD.

As the virus has spread, so have testing capabilities. For example, the Army initially had nine medical centers with a large testing capacity. That's since expanded to 35 installations to provide testing locally, said Army Lt. Gen. Scott Dingle, the Army surgeon general.

Medical lab professionals are also investigating different diagnostic capabilities, Dingle said. And they're working on the development of a COVID-19 vaccine.

COVID-19 testing is just the latest capability of MHS laboratory professionals. At Naval Medical Center San Diego, the laboratory staff of 260 performs and analyzes about 4 million medical tests annually, said Teresita Crisostomo, the lab quality assurance supervisor.

"Working in the lab every day is a surprise and unpredictable," Moeun said. "You never know what you will encounter, or how you can help a patient's treatment."

"We are behind the scenes in a patient’s care, performing hundreds of different tests," added Capt. Crystal Davis, chief of the core laboratory. "We never underestimate how important our role is, and truly believe it's the best job ever."

Added Senior Airman Jadon Smith, a core laboratory technician: "Doctors rely on us for results. We are critical to the care of a patient."

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy

U.S. Navy/U.S. Marine Corps COSC Policy Update

Policy
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.